Article: Nicotinamide Riboside Supplementation Does Not Disrupt Methylation, Including in Individuals with MTHFR Mutations: Clinical Findings

Clinical Neurological Health Parkinson's Disease

Nicotinamide Riboside Supplementation Does Not Disrupt Methylation, Including in Individuals with MTHFR Mutations: Clinical Findings

Objectives

To investigate the impact of NR supplementation on DNA methylation patterns in the blood cells and muscle tissues of newly diagnosed, dopaminergic treatment-naïve Parkinson's disease (PD) patients.

Journal

iScience

Key Outcomes

NR supplementation had no impact on DNA methylation in PD patients, including in those with common mutations in the MTHFR gene.
NR also resulted in minor changes in the activity of metabolic pathways and patterns of DNA methylation. However, these changes were not harmful and did not disrupt normal DNA methylation.

Duration

30 days

Dose

1000 mg

Study Design

Randomized, double-blind, placebo-controlled, phase I study in 29 newly diagnosed Parkinson's disease (PD) patients

See Published Study

Alzheimer's Disease

Nicotinamide Riboside Supplementation Combined with Metabolic Activators Improves Cognitive Function in Alzheimer’s Disease: Clinical Findings

Objectives To investigate whether supplementation of combined metabolic activators (CMA) consisting of L-carnitine tartrate, nicotinamide riboside (NR), serine, and N-acetyl-L-cysteine (NAC), coul...

Clinical

Nicotinamide Riboside Supplementation May Influence Bacterial Composition: Clinical Findings

Objectives To explore the effects of NR supplementation on the gut microbiota composition in humans. Journal npj Aging Key Outcomes NR supplementation did not affect the diversity or abundance of ...